Lyft plans to build a hybrid network of autonomous and driver vehicles, co-founder says

Lyft plans to build a hybrid network of autonomous and driver vehicles, co-founder says


Lyft’s vehicle fleet will remain largely commandeered by drivers even as the company continues to develop its autonomous driving capabilities, co-founder and president John Zimmer told CNBC’s Jim Cramer on Tuesday.

“What we see happening is that there will be a hybrid network, meaning on day 1, just like what happened with phones, you didn’t have 3G go to 4G go to 5G on separate networks. You still needed to be able to make a 3G call when 4G wasn’t available,” Zimmer said in an interview on “Mad Money.”

“The same thing’s going to be true with autonomous vehicles. … It’ll do five percent of the trips. 95% of the time you’re going to rely on a rideshare driver. So that’s all going to happen within the Lyft network, and we’ll scale up with our autonomous partners,” he added.

Lyft Autonomous’ AV partners include Ford Motors and Argo AI, Motional and Waymo. Lyft announced in 2021 that it will launch a driverless robotaxi service in Las Vegas next year through its partnership with Motional.

Zimmer also told Cramer that the rideshare platform has seen “a 40% active drivers year-over-year improvement,” and that productivity has been higher, with Lyft facilitating 20% more rides per driver compared to during the first quarter in 2019.

Soaring gas prices led to a shortage of rideshare drivers earlier in the year, and the Covid pandemic kept Lyft drivers off the road before that.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More